New Approaches for the Treatment of Alzheimer’s Disease

Cited by (193)

Items 101–193 of 193

1. Integrative analysis reveals key lysosomal genes as potential therapeutic targets in Alzheimer’s disease
   Xiangzhen Zhu, Jingfang Gao, Chao Qiu · 2024 · Metabolic Brain Disease
2. Deep learning-based reconstruction enhanced image quality and lesion detection of white matter hyperintensity through in FLAIR MRI
   Jie Sun, Chun Xiao Bu, Jing Dang, Qing qing Lv, Qiuying Tao, Yi Kang, Xiaoyu Niu, Baohong Wen, Wei Jian Wang, Kai Yu Wang et al. · 2024 · Asian Journal of Surgery
3. Changes in Expression of Key Genes in Alzheimer’s Disease: A Specific Brain Tissue Change
   Lucas Trevizani Rasmussen, Roger Willian de Lábio, Mônica Pezenatto dos Santos, Bruno Mari Fredi, Eduardo Federighi Baisi Chagas, Elizabeth Chen, Gustavo Turecki, Marı́lia de Arruda Cardoso Smith, Spencer Luíz Marques Payão · 2024 · The Journals of Gerontology Series A
4. Development of quantitative detection methods for four Alzheimer’s disease specific biomarker panels using electrochemical immunosensors based on enzyme immunoassay
   Il Kyu Park, Young Sun Choi, Seo Yun Jo · 2024 · Analytical Sciences
5. Rehabilitation effects of game therapy in people living with dementia: A systematic review and meta‐analysis
   Jiashuai Li, Yang Guo, Kaixi Yang, Guoyu Zhang, Kexiang Huang, Jia Zhou, Yue Sun, Zhiwen Wang · 2023 · Worldviews on Evidence-Based Nursing
6. Introduction to Neurodegenerative Diseases
   Reihaneh Seyedebrahimi, Piao Yang, Maryam Azimzadeh, Mohsen Eslami Farsani, Shima Ababzadeh, Naser Kalhor, Mohsen Sheykhhasan · 2024 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
7. Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer’s disease mice
   Ruowen Guo, 中国科学院合肥物质科学研究院, 中国科学院强磁场与离子束物理生物学重点实验室, 安徽 合肥 230031, 中国, Wenjing Xie, Biao Yu, Chao Song, Xinmiao Ji, Xinyu Wang, Mei Zhang, Xin Zhang, 中国科学技术大学研究生院科学岛分院, 安徽 合肥 230036, 中国 et al. · 2024 · 动物学研究
8. Alzheimer’s Disease: Perspective on Therapeutic Options and Recent Hallmarks in Clinical Research
   B. AUBINE MOLLY, Sarvan Manikiran Seethamraju, Lakshmi Prasanthi Nori · 2021 · International Journal Of Pharmaceutical Research And Allied Sciences
9. Alzheimer’s Disease: Understanding Its Novel Drug Delivery Systems and Treatments
   Hitaansh Dhingra, Sonali Gajanan Choudhari · 2022 · Cureus
10. Synthesis and structure–activity relationship (SAR) studies of 1,2,3-triazole, amide, and ester-based benzothiazole derivatives as potential molecular probes for tau protein
    Hendris Wongso, Maiko Ono, Tomoteru Yamasaki, Katsushi Kumata, Makoto Higuchi, Ming‐Rong Zhang, MICHAEL J. FULHAM, Andrew G. Katsifis, Paul Anthony Keller · 2023 · RSC Medicinal Chemistry
11. The effects of tea polyphenols on emotional homeostasis: Understanding dementia risk through stress, mood, attention & sleep
    Donné Minné, Juliet Stromin, Taskeen Fathima Docrat, Penelope C. Engel-Hills, Jeanine Lucasta Marnewick · 2023 · Clinical Nutrition ESPEN
12. Petrosamine isolated from marine sponge Petrosia sp. demonstrates protection against neurotoxicity in vitro and in vivo
    Joana Ribeiro, Henrique Araújo-Silva, Mario Sérgio Fernandes, Joilna Alves da Silva, Francisco das Chagas Lima Pinto, Otília Deusdênia Loiola Pessoa, Hélcio Silva dos Santos, Jane Eire Silva Alencar de Menezes, Andreia Castro Gomes · 2024 · Natural Products and Bioprospecting
13. Effect of woohwangchungsimwon and donepezil co-treatment on cognitive function and serum metabolic profiles in a scopolamine-induced model of Alzheimer's disease
    Jung-Seop Kim, Man Gi Kim, Ji Eun Ryu, Ye-Been Lee, Quan Feng Liu, Kwang Ki Kim, Seung‐Hun Cho, Sung Joon Shin, Byung-Soo Koo, Hyung‐Kyoon Choi · 2023 · Journal of Ethnopharmacology
14. Di-caffeoylquinic acid: a potential inhibitor for amyloid-beta aggregation
    Yue Sun, Xue Wang, Xiaoyu Zhang, Yan Li, Dongdong Wang, Feng Sun, Cunli Wang, Zhenqiang Shi, Xindi Yang, Zhiying Yang et al. · 2024 · Journal of Natural Medicines
15. Phyto-Active Components Delivered through Lipid Nanodrug Carriers as a Promising Avenue for the Treatment of Alzheimer’s Disease: Their Present Status and Industrial Viability
    Mr. Abhishek Mishra, Pratap Kumar Sahu, Bhabani Sankar Satapathy, Biswabhusan Biswal · 2024 · Current Nanomaterials
16. Volume Changes in Brain Subfields of Patients with Alzheimer’s Disease After Transcranial Ultrasound Stimulation
    Sheng‐Yao Huang, Meng-Ting Wu, Chung-Fu Sun, Feng‐Yi Yang · 2025 · Diagnostics
17. Effects of acupuncture on dementia: An overview of systematic reviews
    Shiqi Ma, Haipeng Huang, Mengqi Li, Bin Yu, Liying Zhang, Ke Huang, Mengyuan Li, Lin Yao, Hongfeng Wang · 2020 · European Journal of Integrative Medicine
18. Neuroprotective Effects of Davallia mariesii Roots and Its Active Constituents on Scopolamine-Induced Memory Impairment in In Vivo and In Vitro Studies
    Chung Hyeon Lee, Min Sung Ko, Ye-Seul Kim, Ju Eon Ham, Jee Yeon Choi, Kwang Woo Hwang, So‐Young Park · 2023 · Pharmaceuticals
19. Piano-stool metal complexes as inhibitors of amyloid-β aggregation in vitro and in vivo
    Gloria Vigueras, Raimon Sabaté, Leoní Alejandra Barrios, Ana Belén Caballero, Samanta Hernández‐García, Pau Bayón, Fernando Gandía‐Herrero, José Ruiz, Patrick Gámez · 2024 · Inorganic Chemistry Frontiers
20. Pharmacological Potential of Bioactive Peptides for the Treatment of Diseases Associated with Alzheimer's and Brain Disorders
    Jeetendra Kumar Gupta, Kuldeep Singh · 2023 · Current Molecular Medicine
21. Stem cells strike back: advancements in Alzheimer’s and Parkinson’s disease treatment and modeling efforts from 2019 to 2024
    Jasmina Isaković, Anna Athanassiadis, Marian Khubeis · 2025 · Journal of Molecular Medicine
22. Efficacy and mechanisms of Icariin in the treatment of Alzheimer's disease: a systematic review and meta-analysis of a preclinical study
    Jingdong Cui, Rui Huang, Xiaoyu Dong · 2026 · European Journal of Pharmacology
23. A review: From old drugs to new solutions: The role of repositioning in alzheimer’s disease treatment
    Fawad Ali Shah, Halima Qadir, Jehanzeb Khan, Muhammad Faheem · 2025 · Neuroscience
24. Alzheimer Hastalığı Tedavisindeki Güncel Yaklaşımlar
    Makbule Dilara ODABAŞI, Zekiye Tuba TÜYLÜ KÜÇÜKKILINÇ · 2021 · Hacettepe University Journal of the Faculty of Pharmacy
25. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's diseases
    Manorama Bhandari, R.K. Tiwari, Silpi Chanda, Gunjan Vasant Bonde · 2024 · Elsevier eBooks
26. Understanding the pathophysiology of alzheimer's disease
    Sanad Samah Alharbi, Sanad Samah Alharbi, ‏Anood Fhid Alanazi, ‏Razan Walid Alomran · 2022 · International Journal of Health Sciences
27. Combining GWAS Summary Data and Proteomics Identified Potential Drug Targets in Dementia
    Yingjie Zhao, Fei Lu, Yongtao Duan · 2025 · Molecular Neurobiology
28. Design, synthesis, and biological evaluation of β-secretase inhibitors: An integrated study of molecular docking, dynamics, pharmacokinetics, quantum chemistry, and in-vitro analysis for Alzheimer's disease
    Yamini Patel, Pratibha Sharma, Ashok Kumar, Hamendra Singh Parmar, Gajendra Kumar Inwati · 2025 · Bioorganic Chemistry
29. Amyloid fibril cytotoxicity and associated disorders
    Sabereh Saremi, Khosro Khajeh · 2024 · Progress in molecular biology and translational science
30. Trends and hotspots in tea and Alzheimer's disease research from 2014 to 2023: A bibliometric and visual analysis
    Xuefang Meng, Wei Cui, Qian Liang, Bo Zhang, Yingxiu Wei · 2024 · Heliyon
31. Decoying the enemy: soluble receptor for advanced glycation end products and cognitive impairment in neurodegenerative diseases—a systematic review and meta-analysis
    Ngakan Putu Krishna Mahayana, Ni Putu Wulandari Putri Yadmika, Made Dhiyo Wiweka Aryaweda, Made Dwinanda Prabawa Mahardana, Christo Timothy Mamangdean, Ni Nyoman Ayu Dewi, Chandra Wirawan, Anak Agung Ayu Putri Laksmidewi · 2024 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
32. Pharmacokinetics, Mechanism, and Docking Study of Antioxidant Aryl‐Bisthiourea Derivatives for Alzheimer's Disease
    Ali Bahadur, Shahid Iqbal, Muhammad Shoaib, Muhammad Zulqarnain, Mazloom Shah, Hisham S. M. Abd‐Rabboh, Usama Perwez, Muhammad Abdul Qayyum, Ajmal Zaman · 2021 · ChemistrySelect
33. Herbal Plethora for Management of Neurodegenerative Disorders: An Invigorating Outlook
    Garima Yadav, Tarique Mahmood, Arshiya Shamim, Supriya Roy, Mohd Masih Uzzaman Khan, Farogh Ahsan, Mohammad Shariq, Saba Parveen, Rufaida Wasim · 2021 · Current Nutrition & Food Science
34. A Brief Review of Alzheimer’s Disease
    Mohammad Davood Yavari · 2021 · Biomedical Journal of Scientific & Technical Research
35. Evaluation of the state of pharmaceutical supply of patients with dementia with Alzheimer disease in Ukraine in accordance with international recommendations
    M. S. Fedotova, Hanna Panfilova, Liliia O. Hala, Alla Lebedyn, Liusine Simonian, О. В. Геруш, Gennadii Iurchenko, Аlina Palamar, Н. В. Шолойко, Mariia Velia · 2022 · ScienceRise Pharmaceutical Science
36. Recent Advances in Approved, Withdrawn, Experimental and Investigational Drugs in Clinical Trials for Alzheimer’s disease
    Rajlaxmi Deshpande · 2022 · Medicinal & Analytical Chemistry International
37. Enzymatic Screening of β-Amyloid Precursor Protein-Based Substrates
    Reo Yamada, Masaki Midorikawa, Ayu Asai, Norimasa Takasu, R. Fujii, Taeko Kakizawa · 2023 · Compounds
38. Ever-expanding landscape: Alzheimer’s—New targets and new patents
    Egunlusi, Ayodeji O, Joubert, Jacques · 2022 · Pharmaceutical Patent Analyst
39. The study of the state of pharmaceutical care for patients with dementia in Alzheimer’s disease in Ukraine
    M. S. Fedotova, Hanna Panfilova · 2024 · Social pharmacy in health care
40. Current Treatment Approaches for Alzheimer’s Disease and Possible Drug Targets
    Ashutosh Ranjan, Shashikesh Shukla, Shamsher Singh · 2024 · Current Drug Therapy
41. Pattern and treatment of Alzheimer's disease at different health care levels in Bangladesh: a hospital based survey
    M. Muhtamim Hussain Rifat, Most. Nazma Parvin, Md. Lokman Hossain · 2025 · International Journal of Community Medicine and Public Health
42. Development of a Robust QSAR Model to Predict the Affinity of N-Bridged Bicyclic Sulfonamide, Pyrazole/Sulfonamide Based Dihydroquinoline and Sulfonamide –Pyrazolopiperidine γ-secretase Inhibitors
    Suman Sharma, Pragya Sharma, Sarvesh Paliwal, Qumar Negar · 2025 · Current Enzyme Inhibition
43. Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus
    Angamuthu Prabakaran, Amuthulakshmi Sivaperuman, Ramalakshmi Natarajan, Nalini Calambur Nagarajan, Viswas Raja Solomon · 2026 · Mini-Reviews in Medicinal Chemistry
44. Investigating the anti-Alzheimer potential of biogenic compounds from Zinc15 database as NMDA antagonist: An in-silico approach
    Somdatta Y. Chaudhari, Asavari R. Shinde, Mukund Salunke, Shriram Bairagi, Azad Nabilal Dhage, Pinkal H. Patel, Vivek Digamber Rathod, Sandeep S. Pathare, Nojood A. Altwaijry, Mohd Shahnawaz Khan · 2026 · Journal of Molecular Graphics and Modelling
45. The potential of HDAC inhibitors for Alzheimer’s disease
    Vedika Jain, Sharda Bharti · 2026 · International review of neurobiology
46. The effect of Alzheimer's blanket activity program on behavioral symptoms, activities of daily living, and quality of life
    Mükerrem Kabataş Yıldız, Ayşe Çal · 2022 · Perspectives In Psychiatric Care
47. Novel Pharmacological Approach to the Treatment of Alzheimer’s Disease
    Manoj Sarjerao Doiphode -, Pallavi Tukaram Jadhav - · 2022 · International Journal For Multidisciplinary Research
48. Parkinson-Krankheit und Demenz vom Alzheimer-Typ – Pathophysiologie und medikamentöse Therapieansätze
    Richard C. Dodel · 2023 · Die Innere Medizin
49. The development of cerebral vasculature and related diseases
    Junchi Ma, Xiaoli Min, Mei Wu, Jingjing Zhang · 2023 · Scientia Sinica Vitae
50. Shifting Paradigm in Early Detection and Prediction of Alzheimer's Disease
    Tabassum Bashir, Deoshree Akhouri, Hamza Hamza · 2024 · Advances in medical technologies and clinical practice book series
51. Alzheimer’s disease: Systematic review of recent substantial therapeutic targets
    Nikita Sharma, Manpreet Kaur Aulakh · 2024 · AIP conference proceedings
52. Drug Delivery Strategies in Alzheimer’s Disease
    Govind Hake, Akshada S. Mhaske, Rahul Shukla · 2023 · Springer eBooks
53. Visualizing Intracellular Localization of Natural-Product-Based Chemical Probes Using Click-Correlative Light and Electron Microscopy
    Eva Schaller, Julian Hofmann, Pamela A Maher, Christian Stigloher, Michael W. Decker · 2025 · ACS Chemical Biology
54. New Perspectives for Treatment in Alzheimer’s Disease
    Júlia Cunha Loureiro, Luiz Fernando de Almeida Lima e Silva, Marcos Vasconcelos Pais, Orestes Vicente Forlenza · 2022 · Springer eBooks
55. Investigating Antialzheimer Potential of Biogenic Compounds From Zinc 15 Database As NMDA Antagonist: A Insilico Approach.
    Somdatta Y. Chaudhari, Asavari R. Shinde, Pratiksha R. Madar, Aarti Vijayakumar Shingan, Shriram Bairagi, Azad Nabilal Dhage, Pinkal H. Patel, Vivek Digamber Rathod, Shailaja B. Jadhav, P. Chaudhari · 2023 · Research Square
56. Clinical Research Progress of Alzheimer’s Disease
    晓峰 李 · 2020 · Advances in Clinical Medicine
57. Bibliothèque
    F. Lagrange · 2019 · Le Pharmacien Hospitalier et Clinicien
58. A Review on: Alzheimer’s disease and mechanistic insights of bioactive compounds in its treatment
    Arvind Kumar · 2022 · YMER Digital
59. Use of artificial pancreas in management of diabetes mellitus
    Abhishek Abhishek, Sourav Pahwa · 2022 · Journal of Applied Pharmaceutical Research
60. Results of the clinical and economic analysis of the state of pharmaceutical provision of patients with dementia in Alzheimer’s disease in Ukraine
    M. S. Fedotova, Hanna Panfilova, Г. М. Юрченко, Аlina Palamar, Л. В. Терещенко, A. A. Kliuiko, Alla Lebedyn, В. М. Чернуха · 2022 · Social pharmacy in health care
61. Planejamento e estudo in silico de derivados de 6-gingerol como inibidores de acetilcolinesterase comparados a donepezila
    Felipe Vitório · 2022 · Revista Brasileira Multidisciplinar
62. Systems pharmacology and multi-scale mechanism of Enicostema axillare bioactives in treating Alzheimer disease
    Madhana Vigneshwari Gopal Samy, Sasidharan Perumal · 2023 · Inflammopharmacology
63. Recent progress in the pathology, diagnosis, and treatment of Alzheimer’s disease
    Xiangning Yu · 2023 · Theoretical and Natural Science
64. An overview on Alzheimer’s disease, diagnosis and treatment approach
    Nivetha S.R, Shivani K, R Vigneshwaran, Gade Lakshmi Prasanna, M Veeramani · 2023 · International Journal of Allied Medical Sciences and Clinical Research
65. Research Progress of Chemical Synthesis Drugs and Biotechnology Drugs for Alzheimer’s Disease
    学权 陈 · 2024 · Open Journal of Natural Science
66. Terapias emergentes para o tratamento da doença de alzheimer
    Bruna Seffrin Soares, Mariana Vasconcelos de Medeiros Chaves, André Cades Barbosa Paz Oliveira de Melo, Diego Almeida Alves, Deley Carneiro Pereira Souza, Mathias Gomes de Cena, Rafael Ferreira Pereira, Rodrigo Tavares Hernandez, Tibério César Meneses de Oliveira Sinimbu, Henrique Estevam Fernandes Amaral et al. · 2024 · Journal of Medical and Biosciences Research.
67. Orexin Receptor System: Molecular Insights and Therapeutic Implications
    Prachi Sharma, Gunjan Choudhary, Monika Sachdeva, Geetika Mehta, Rashmi Tripathi · 2024 · Current Drug Therapy
68. Alzheimer's disease – An overview of nano herbal formulations
    Vishal Shivaji Patil, Shrikant Patil, Snehal Rajendra Patil, Akanksha Shahaji Pawar, Amol Somnath Shete · 2025 · Pharmacological Research - Reports
69. Synthesis of substrate peptides incorporating non-natural amino acids and screening study using BACE1
    Shinji Katsuoka, Ryo Watanabe, Yuma Uchida, Masaki Midorikawa, Reo Yamada, Taeko Kakizawa · 2025 · Bioorganic & Medicinal Chemistry Letters
70. Design, Synthesis, and Biological Evaluation of Β-Secretase Inhibitors: An Integrated Study of Molecular Docking, Dynamics, Pharmacokinetics, Quantum Chemistry, and In-Vitro Analysis for Alzheimer's Disease
    Yamini Patel, Pratibha Sharma, Ashok Kumar, Hamendra Singh Parmar, Gajendra Kumar Inwati · 2025 · SSRN Electronic Journal
71. New Approaches to the Drug Molecule: Essential Oil and Pyridazinone Derivative Molecules
    Okan Aykaç, Umut Okur, Recep Ogün Demirci, Tuba Öner, Gülce Taşkor Önel, İrem Bozbey Merde · 2025 · Anatolian Journal of Pharmaceutical Sciences
72. Current therapies for the treatment of Alzheimer's disease
    Laura A. Finn · 2025 · Elsevier eBooks
73. Additional file 1 of The role of geographic information system and global positioning system in dementia care and research: a scoping review
    Neda Firouraghi, Behzad Kiani, Jafari, Hossein Tabatabaei, Vincent Learnihan, José Alberto Salinas-Pérez, Ahmad Raeesi, Furst, MaryAnne, Salvador-Carulla, Luis, Nasser Bagheri · 2022 · Figshare
74. Additional file 4 of The role of geographic information system and global positioning system in dementia care and research: a scoping review
    Neda Firouraghi, Behzad Kiani, Jafari, Hossein Tabatabaei, Vincent Learnihan, José Alberto Salinas-Pérez, Ahmad Raeesi, Furst, MaryAnne, Salvador-Carulla, Luis, Nasser Bagheri · 2022 · Figshare
75. Additional file 2 of The role of geographic information system and global positioning system in dementia care and research: a scoping review
    Neda Firouraghi, Behzad Kiani, Jafari, Hossein Tabatabaei, Vincent Learnihan, José Alberto Salinas-Pérez, Ahmad Raeesi, Furst, MaryAnne, Salvador-Carulla, Luis, Nasser Bagheri · 2022 · Figshare
76. Additional file 3 of The role of geographic information system and global positioning system in dementia care and research: a scoping review
    Neda Firouraghi, Behzad Kiani, Jafari, Hossein Tabatabaei, Vincent Learnihan, José Alberto Salinas-Pérez, Ahmad Raeesi, Furst, MaryAnne, Salvador-Carulla, Luis, Nasser Bagheri · 2022 · Figshare
77. Additional file 1 of Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions
    Byung Woo Kang, Kim, Fred, Cho, Joon-Yong, Kim, SangYun, Jinseol Rhee, Choung, Jai Jun · 2022 · Figshare
78. Association between open angle glaucoma and early onset Alzheimer's disease
    Yuto Yoshida, Nobuaki Michihata, Masaki Tanito, Yoshimune Hiratsuka, Shintaro Nakao, Hideo Yasunaga · 2025 · Journal of Alzheimer s Disease
79. Alzheimer Hastalığı Tedavisindeki Güncel Yaklaşımlar
    Makbule Dilara ODABAŞI, Zekiye Tuba TÜYLÜ KÜÇÜKKILINÇ · 2021 · DergiPark (Istanbul University)
80. Exploration de nouveaux biomarqueurs plasmatiques pour le diagnostic de la maladie d’Alzheimer
    Emilie Rossi · 2021
81. Use of nanoliposomes rich in omega-3 for the prevention of neurodegenerative diseases : bioavailability in vivo and in cortical neurons
    Elodie Passeri · 2021 · theses.fr (ABES)
82. Design and synthesis of trisubstituted 1,2,4-triazoles : structural exploration in the inhibition of GSK-3β for the treatment of Alzheimer’s disease
    Thiago M. Pereira · 2024 · theses.fr (ABES)
83. Case Studies and Patents in Alzheimer’s Disease Research
    Deepak Kumar, Piyush Anand, Juhi Tiwari, S. N. Singh · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
84. Microfluidics devices for neurological disorders
    Devangi Zala, Shuvomoy Banerjee, Anand Krishna Tiwari · 2026 · Progress in molecular biology and translational science
85. Discovery of New Butyrylcholinesterase Inhibitors and Evaluation of Their Biological Activity against Alzheimer’s Disease
    Qinghong Liao, Xiaohan Wang, Y. B. Duan, Lina Guo, Siyu He, Weiping Lyu, Jiahe Shi, Ruihao Fu, Huachen Zhang, Yantao Han et al. · 2026 · ACS Chemical Neuroscience
86. THERAPY FOR ALZHEIMER’S DISEASE - FOCUS ON LECANEMAB
    Mikołaj Jońca, Gabriela Majchrowicz, Natasza Kurys, Weronika Piekarska, Szymon Litke, Katarzyna Gołacka · 2026 · International Journal of Innovative Technologies in Social Science
87. Modulation of spatial learning and memory by cannabinoid–estrogen interaction in an AD-like cognitive impairment: The role of cannabinoid receptors and BDNF protein
    Mohammad Ali Mirshekar, Farzaneh Nadi, Hamed Fanaei, Mohadeseh Chahkandi · 2026 · IBRO Neuroscience Reports
88. 1,3,4-Oxadiazole–sulfonamide hybrids: recent advances in biological activities, structure–activity relationships, and therapeutic applications
    Alshaimaa Hosney, Elshimaa M. N. Abdelhafez, Mamdouh F. A. Mohamed · 2026 · RSC Advances
89. Translating Molecular Pathogenesis into Therapeutics: Emerging Strategies and Clinical Prospects for Alzheimer’s Disease
    Mona Piplani, Shivani Thakur, Pankaj Kumar, Sourbh Suren Garg, Ankush Goyal, Pradeep Goyal · 2026 · Biomedical & Pharmacology Journal
90. BindingDB Entry 50012147: Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation.
    BindingDB · 2022 · UC San Diego
91. BindingDB Entry 50019082: Synthesis and structure-activity relationship (SAR) studies of 1,2,3-triazole, amide, and ester-based benzothiazole derivatives as potential molecular probes for tau protein.
    BindingDB · 2024 · UC San Diego
92. BindingDB Entry 50011384: TBA
    BindingDB · 2022 · UC San Diego
93. BindingDB Entry 50013305: N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    BindingDB · 2022 · UC San Diego